Sensory processing study for early psychosis
Part of Mental health clinical trials.
This study looks at how people at different stages of psychosis process sensory information like vision and hearing. It may help us understand early signs and improve treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 30 years old
- You have normal or corrected vision
- You speak French fluently and are covered by French health insurance
- You do not have certain eye conditions, seizures, or substance use problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how a “patient guide” (Patientheque) may help young people who are either having a first psychosis episode or showing early warning signs. It aims to support care decisions and reduce stress by improving understanding and follow-up.
This study looks at people who have had psychosis for less than 4 years to understand how their symptoms change over time and how they respond to treatment. By using brain scans and other tests, researchers hope to find better ways to personalize care for early psychosis.
This study looks at how people with schizophrenia or bipolar disorder see the world. By comparing their visual perception to people without these conditions, researchers hope to learn more about how the brain processes what we see.
This study uses a short EEG recording to look at brain activity patterns in young people with early signs of mental health conditions, including those at risk for psychosis, first episode psychosis, depression, or autism. It aims to find brain markers that could help identify people who might benefit from early treatment.
This study looks at how people with schizophrenia process sensory information and make predictions. It aims to understand disruptions in these processes to improve future treatments.
This study follows people with early psychosis, or a high risk of developing psychosis, to better understand brain and symptom changes over time. It may help future prevention or treatment by comparing brain/clinical measurements between people who are at risk, recently affected, and healthy controls.
Hear when a new Early Psychosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.